FOL100
- Generic Name
- FOL100
Study to Evaluate Safety & Usability of a New Formulation for Male Androgenetic Alopecia
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Follicle Pharma Ltd
- Target Recruit Count
- 90
- Registration Number
- NCT05611593
- Locations
- 🇮🇱
Sourasky Medical Center, Tel Aviv, Israel
🇮🇱Rabin Medical Center, Petah tikva, Israel
🇮🇱Sheba Medical Center, Ramat Gan, Israel
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath